共 13 条
[1]
Blackmon JT., 2016, J Neurol Neuromedicine, V1, P39, DOI [10.29245/2572.942X/2016/4.1040, DOI 10.29245/2572.942X/2016/4.1040]
[4]
Food and Drug Administration, 2018, TECENTRIQ AT INJ INT
[5]
Natalizumab may control immune checkpoint inhibitor-induced limbic encephalitis
[J].
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION,
2018, 5 (02)
[8]
Atezolizumab-related encephalitis in the intensive care unit: Case report and review of the literature
[J].
SAGE OPEN MEDICAL CASE REPORTS,
2018, 6